Clinical significance of serum S100 calcium-binding protein A4 in idiopathic pulmonary fibrosis.
Norimichi AkiyamaHironao HozumiTakuya IsayamaJun OkadaKatsunori SugiuraHideki YasuiYuzo SuzukiMasato KonoMasato KarayamaKazuki FuruhashiNoriyuki EnomotoTomoyuki FujisawaNaoki InuiYutaro NakamuraTakafumi SudaPublished in: Respirology (Carlton, Vic.) (2019)
S100A4 is a promising serum biomarker that may help predict disease progression/mortality. Our findings may help establish treatment strategies for IPF.